Stocks and Investing
Stocks and Investing
Fri, April 3, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Turnure Maintained (SRE) at Hold with Decreased Target to $63 on, Apr 3rd, 2020
Christopher Turnure of JP Morgan, Maintained "Sempra" (SRE) at Hold with Decreased Target from $76 to $63 on, Apr 3rd, 2020.
Christopher has made no other calls on SRE in the last 4 months.
There are 9 other peers that have a rating on SRE. Out of the 9 peers that are also analyzing SRE, 5 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- James Thalacker of "BMO Capital" Maintained at Hold with Decreased Target to $56 on, Thursday, March 26th, 2020
- Sophie Karp of "Keybanc" Downgraded from Buy to Hold on, Friday, March 13th, 2020
- Stephen Byrd of "Morgan Stanley" Maintained at Hold with Decreased Target to $77 on, Thursday, March 12th, 2020
- Ryan Levine of "Citigroup" Maintained at Hold with Decreased Target to $76 on, Wednesday, March 4th, 2020
- Anthony Crowdell of "Mizuho" Initiated at Hold and Held Target at $82 on, Friday, February 7th, 2020
These are the ratings of the 4 analyists that currently disagree with Christopher
- Eric Beaumont of "Barclays" Maintained at Buy with Decreased Target to $62 on, Thursday, March 26th, 2020
- Daniel Ford of "UBS" Maintained at Strong Buy with Decreased Target to $68 on, Monday, March 23rd, 2020
- Christopher Muir of "CFRA" Upgraded at Strong Buy and Decreased Target to $60 on, Wednesday, March 18th, 2020
- Jacob Kilstein of "Argus Research" Maintained at Strong Buy with Increased Target to $82 on, Thursday, December 26th, 2019